Acrodermatitis continua Hallopeau successfully treated by risankizumab. Hugo J, Gkalpakioti P, Arenbergerova M, Arenberger P, et al. Int J Dermatol 2021;60:e144-e145.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hugo J, Gkalpakioti P, Arenbergerova M, Arenberger P, et al. Acrodermatitis continua Hallopeau successfully treated by risankizumab. Int J Dermatol 2021;60:e144-e145.
PMID: 33368238